FDA Clarifies Approach To Pediatric Drug Development - Life Sciences, Biotechnology & Nanotechnology
On May 17, the U.S. Food & Drug Administration ("FDA") issued two important draft guidance documents, which clarify the agency's approach to requirements and incentives in the realm of pediatric drug development...
United States Pediatric Drug Development Us Food Drug Administration Jan Drug Administration Research Equity Food Drug Administration Feb
Source: mondaq.com